Page last updated: 2024-08-16

salmeterol xinafoate and Allergic Bronchopulmonary Aspergilloses

salmeterol xinafoate has been researched along with Allergic Bronchopulmonary Aspergilloses in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bond, RA; Corry, DB; Frazier, V; Kheradmand, F; Kim, C; Kim, JJ; Knight, JM; Luong, A; Mak, G; Mandal, PK; McDermott, C; McMurray, JS; Millien, VO; Milner, JD; Porter, P; Qian, Y; Roberts, L; Shaw, J; Song, LZ; You, R; Yuan, X; Zhang, Y1

Other Studies

1 other study(ies) available for salmeterol xinafoate and Allergic Bronchopulmonary Aspergilloses

ArticleYear
Long-Acting Beta Agonists Enhance Allergic Airway Disease.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Anti-Asthmatic Agents; Arrestins; Aspergillosis, Allergic Bronchopulmonary; Aspergillus niger; Asthma; beta-Arrestins; Bronchoconstriction; Carbazoles; Carvedilol; Disease Models, Animal; Female; Formoterol Fumarate; Gene Expression; Humans; Lung; Mice; Mice, Knockout; Peptidomimetics; Propanolamines; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; STAT6 Transcription Factor

2015